LACRIFILL®
Dry eye treatment, reinvented.
When Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., wanted a compelling brand and launch for LACRIFILL® Canalicular Gel, a novel therapy for dry eye symptoms, they partnered with Merz. This important product launch signaled their first offering in the U.S. and was a key milestone in their global expansion strategy.
The Challenge
At the time, Nordic Pharma, Inc. did not have any name recognition with Eye Care Professionals in the U.S. market. In addition, the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting, which was targeted for the launch, was less than six months away. This required an agile team who could develop a strong brand and navigate the medical, legal and regulatory process in order to get to market.
The Solution
Merz used strategy sessions with leadership, industry research and discovery sessions with key opinion leaders to gain the insights needed for the initiative. The team created the brand identity, strategy and positioning, along with all of the brand assets to introduce LACRIFILL® to Ophthalmologists and Optometrists. From the strong launch to continued sales and marketing efforts, Merz partners with the LACRIFILL® team on packaging, sales collateral, webinars, digital campaigns, videos and trade show strategies to grow this innovative brand.
Services
Market ResearchBrand Positioning
Brand Development
Brand Identity & Standards
Graphic Design & Packaging
Omnichannel Marketing Strategy
Integrated Marketing Campaigns
Experiential Marketing
Website Design & Development
Reporting & Analytics
Contact Us
RESULTS
0
Timeline for brand development and launch
0
Sales goals achieved at launch conference
0
Conversion Rate ECPs registering and attending webinar series
